These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28468235)

  • 1. In Search of Sleep Biomarkers of Alzheimer's Disease: K-Complexes Do Not Discriminate between Patients with Mild Cognitive Impairment and Healthy Controls.
    Reda F; Gorgoni M; Lauri G; Truglia I; Cordone S; Scarpelli S; Mangiaruga A; D'Atri A; Ferrara M; Lacidogna G; Marra C; Rossini PM; De Gennaro L
    Brain Sci; 2017 Apr; 7(5):. PubMed ID: 28468235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep spindles, K-complexes, limb movements and sleep stage proportions may be biomarkers for amnestic mild cognitive impairment and Alzheimer's disease.
    Liu S; Pan J; Tang K; Lei Q; He L; Meng Y; Cai X; Li Z
    Sleep Breath; 2020 Jun; 24(2):637-651. PubMed ID: 31786748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the sleep K-complex on the conversion from mild cognitive impairment to Alzheimer's disease.
    Gorgoni M; Cenani J; Scarpelli S; D'Atri A; Alfonsi V; Annarumma L; Pietrogiacomi F; Ferrara M; Marra C; Rossini PM; De Gennaro L
    J Sleep Res; 2024 Feb; 33(1):e14046. PubMed ID: 37718942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parietal Fast Sleep Spindle Density Decrease in Alzheimer's Disease and Amnesic Mild Cognitive Impairment.
    Gorgoni M; Lauri G; Truglia I; Cordone S; Sarasso S; Scarpelli S; Mangiaruga A; D'Atri A; Tempesta D; Ferrara M; Marra C; Rossini PM; De Gennaro L
    Neural Plast; 2016; 2016():8376108. PubMed ID: 27066274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verification of the association between cognitive decline and olfactory dysfunction using a DEmentia screening kit in subjects with Alzheimer's dementia, mild cognitive impairment, and normal cognitive function (DESK study): A multicenter, open-label, interventional study.
    Fukumoto T; Ezaki T; Urakami K
    eNeurologicalSci; 2022 Dec; 29():100439. PubMed ID: 36531966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple cross-frequency coupling analysis of resting-state EEG in patients with mild cognitive impairment and Alzheimer's disease.
    Chen X; Li Y; Li R; Yuan X; Liu M; Zhang W; Li Y
    Front Aging Neurosci; 2023; 15():1142085. PubMed ID: 37600515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
    Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-rapid eye movement sleep instability in mild cognitive impairment: a pilot study.
    Maestri M; Carnicelli L; Tognoni G; Di Coscio E; Giorgi FS; Volpi L; Economou NT; Ktonas P; Ferri R; Bonuccelli U; Bonanni E
    Sleep Med; 2015 Sep; 16(9):1139-45. PubMed ID: 26298791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical epileptiform activity during sleep in Alzheimer's disease and mild cognitive impairment.
    Brunetti V; D'Atri A; Della Marca G; Vollono C; Marra C; Vita MG; Scarpelli S; De Gennaro L; Rossini PM
    Clin Neurophysiol; 2020 May; 131(5):1011-1018. PubMed ID: 32193162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment.
    Meghdadi AH; Stevanović Karić M; McConnell M; Rupp G; Richard C; Hamilton J; Salat D; Berka C
    PLoS One; 2021; 16(2):e0244180. PubMed ID: 33544703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disrupted balance of long and short-range functional connectivity density in Alzheimer's disease (AD) and mild cognitive impairment (MCI) patients: a resting-state fMRI study.
    Mao Y; Liao Z; Liu X; Li T; Hu J; Le D; Pei Y; Sun W; Lin J; Qiu Y; Zhu J; Chen Y; Qi C; Su H; Yu E
    Ann Transl Med; 2021 Jan; 9(1):65. PubMed ID: 33553358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease.
    Ouma S; Suenaga M; Bölükbaşı Hatip FF; Hatip-Al-Khatib I; Tsuboi Y; Matsunaga Y
    Brain Behav; 2018 Mar; 8(3):e00936. PubMed ID: 29541546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blink Rate Study in Patients with Alzheimer's Disease, Mild Cognitive Impairment and Subjective Cognitive Decline.
    D'Antonio F; Bartolo MI; Ferrazzano G; Monti MS; Imbriano L; Trebbastoni A; Berardelli A; Conte A
    Curr Alzheimer Res; 2021; 18(14):1104-1110. PubMed ID: 34961444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between cognitive impairment and CSF biomarkers in amnesic MCI, non-amnesic MCI, and Alzheimer's disease.
    Haldenwanger A; Eling P; Kastrup A; Hildebrandt H
    J Alzheimers Dis; 2010; 22(3):971-80. PubMed ID: 20858947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of plasma matrix metalloproteinase levels on longitudinal changes in Alzheimer's disease (AD) biomarkers and cognitive function in patients with mild cognitive impairment due to AD registered in the Alzheimer's Disease Neuroimaging Initiative database.
    Abe K; Chiba Y; Hattori S; Yoshimi A; Asami T; Katsuse O; Suda A; Hishimoto A;
    J Neurol Sci; 2020 Sep; 416():116989. PubMed ID: 32603972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EEG alterations during wake and sleep in mild cognitive impairment and Alzheimer's disease.
    D'Atri A; Scarpelli S; Gorgoni M; Truglia I; Lauri G; Cordone S; Ferrara M; Marra C; Rossini PM; De Gennaro L
    iScience; 2021 Apr; 24(4):102386. PubMed ID: 33981973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual Time-Point [18F]Florbetaben PET Delivers Dual Biomarker Information in Mild Cognitive Impairment and Alzheimer's Disease.
    Florek L; Tiepolt S; Schroeter ML; Berrouschot J; Saur D; Hesse S; Jochimsen T; Luthardt J; Sattler B; Patt M; Hoffmann KT; Villringer A; Classen J; Gertz HJ; Sabri O; Barthel H
    J Alzheimers Dis; 2018; 66(3):1105-1116. PubMed ID: 30400095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory function changes and the predictive performance of the Chinese Smell Identification Test in patients with mild cognitive impairment and Alzheimer's disease.
    Mi Y; Ma X; Du S; Du C; Li X; Tan H; Zhang J; Zhang Q; Shi W; Zhang G; Tian Y
    Front Aging Neurosci; 2023; 15():1068708. PubMed ID: 36861124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Brain Lateralization in Patients with Mild Cognitive Impairment and Alzheimer's Disease: A Resting-State Functional Magnetic Resonance Study from Alzheimer's Disease Neuroimaging Initiative.
    Liu H; Zhang L; Xi Q; Zhao X; Wang F; Wang X; Men W; Lin Q
    Front Neurol; 2018; 9():3. PubMed ID: 29472886
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.